About Conference

The International Congress on Pediatric Neurology, Neurodevelopment & Precision Therapeutics (PedsNeuro 2027) is a premier global forum dedicated to advancing research, innovation, and clinical excellence in child neurology and neurodevelopmental science. Scheduled for March 22-24, 2027 in Singapore and Online as a hybrid conference, this international gathering will unite pediatric neurologists, developmental pediatricians, neuroscientists, geneticists, rehabilitation specialists, translational researchers, and healthcare innovators to explore emerging diagnostics, precision therapeutics, and multidisciplinary care models for neurological disorders in children. With rapid advances in genomics, neuroimaging, biomarker discovery, and AI-assisted diagnostics, pediatric neurology is entering a transformative era that demands collaborative global dialogue.

PedsNeuro 2027 will feature keynote lectures, plenary sessions, expert panels, clinical case discussions, and translational research presentations covering epilepsy, pediatric stroke, neuromuscular disorders, neurogenetic syndromes, autism spectrum disorders, ADHD, cerebral palsy, neuroinflammation, metabolic disorders, and rare pediatric neurological diseases. A strong emphasis will be placed on precision medicine in pediatric neurology, integrating genomics, targeted therapies, personalized rehabilitation, digital health technologies, and early neurodevelopmental interventions. The scientific program is designed to bridge laboratory breakthroughs with clinical implementation, ensuring meaningful outcomes for infants, children, and adolescents affected by neurological conditions.

Singapore, a leading biomedical and neuroscience research hub in Asia, offers an ideal international setting with strong academic infrastructure, global accessibility, and a vibrant pediatric healthcare ecosystem. The hybrid format enables worldwide participation, maximizing knowledge exchange across continents while fostering inclusive collaboration. PedsNeuro 2027 aims to accelerate innovation, strengthen research partnerships, support early-career investigators, and shape the future of child brain health through evidence-based precision therapeutics and multidisciplinary clinical excellence.

Also, collaborated with Mathews Journal of Pediatrics and Mathews Journal of Neurology, the PedsNeuro 2027 benefits from the expertise and dedication of two esteemed journals in the field. These journals, known for publishing groundbreaking research and fostering scientific advancement, are partnering with PedsNeuro 2027 to enhance the quality and reach of the event, bringing in a global network of researchers and healthcare professionals. As part of this collaboration, participants who wish to publish their full-length research articles have the opportunity to submit their manuscripts. This is an excellent platform for researchers and professionals to share their contributions to the field, receive peer-reviewed recognition, and enhance the visibility of their work. Article processing charges are completely free, and submitted manuscripts will only be published after a thorough peer review by the journal's editorial team.

To submit your manuscript, please visit: https://www.mathewsopenaccess.com/submit-manuscript. The journal team is excited to welcome high-quality papers that expand on the topics discussed during the event.